Broad-Spectrum Therapeutic Suppression of Metastatic Melanoma through Nuclear Hormone Receptor Activation

Pencheva, Nora, Buss, Colin G., Posada, Jessica, Merghoub, Taha, Tavazoie, Sohail F.·2014·Cell
DOI 10.1016/j.cell.2014.01.038

Cited by (179)

Items 101–179 of 179

  1. Screening of Focused Compound Library Targeting Liver X Receptors in Pancreatic Cancer Identified Ligands with Inverse Agonist and Degrader Activity
    Husna Karaboga, Wentao Huang, Shivangi Srivastava, Scott Widmann, Sridevi Addanki, Kasuni Thawalama Gamage, Zahra Mazhar, Jerry Osagie Ebalunode, James M. Briggs, Jan-Ακε Gustafsson et al. · 2020 · ACS Chemical Biology
  2. Chronic Activation of LXRα Sensitizes Mice to Hepatocellular Carcinoma
    Yang Xie, Runzi Sun, Li Gao, Jibin Guan, Jingyuan Wang, Aaron W. Bell, Junjie Zhu, Min Zhang, Meishu Xu, Peipei Lu et al. · 2022 · Hepatology Communications
  3. ER-Negative Breast Cancer Is Highly Responsive to Cholesterol Metabolite Signalling
    Samantha A. Hutchinson, Priscilia Lianto, Hanne Røberg‐Larsen, Sebastiano Battaglia, Thomas A. Hughes, James L. Thorne · 2019 · Nutrients
  4. Unveiling tumor immune evasion mechanisms: abnormal expression of transporters on immune cells in the tumor microenvironment
    Lu Chen, Yuchen Wang, Qingqing Hu, Yuxi Liu, Xuchen Qi, Zhihua Tang, Haihong Hu, Nengming Lin, Su Zeng, Lushan Yu · 2023 · Frontiers in Immunology
  5. Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma
    Shruthy Suresh, Roy Rabbie, Manik Garg, Dianne Lumaquin, Ting Hsiang Huang, Emily D. Montal, Yilun Ma, Nelly M. Cruz, Xinran Tang, Jérémie Nsengimana et al. · 2022 · Cancer Discovery
  6. Melanoma-intrinsic NR2F6 activity regulates antitumor immunity
    Hyungsoo Kim, Yong-Mei Feng, Rabi Murad, J. Pozniak, C. Pelz, Yeqing Chen, B. Dalal, R. Sears, E. Sergienko, Michael Jackson et al. · 2022 · bioRxiv
  7. Molecular Landscape and Clinical Implication of CCNE1- amplified Esophagogastric Cancer
    Naryan Rustgi, Sharon Wu, Timothy Samec, Phillip Walker, Joanne Xiu, Emil Lou, Sanjay Goel, Anwaar Saeed, Ryan H. Moy · 2024 · Cancer Research Communications
  8. Independent modes of disease repair by AIM protein distinguished in AIM-felinized mice
    Ryoichi Sugisawa, Ginga Komatsu, Emiri Hiramoto, Naoki Takeda, Ken‐ichi Yamamura, Satoko Arai, Toru Miyazaki · 2018 · Scientific Reports
  9. Shedding light on the roles of liver X receptors in cancer by using chemical probes
    Lorenzo Pontini, Maura Marinozzi · 2020 · British Journal of Pharmacology
  10. Apolipoprotein E2 Stimulates Protein Synthesis and Promotes Melanoma Progression and Metastasis
    Adaku, Nneoma, Ostendorf, Benjamin N., Mei, Wenbin, Tavazoie, Sohail F. · 2023 · Cancer Research
  11. Jun-APOE-LRP1 axis promotes tumor metastasis in colorectal cancer
    Lingyuan He, Mengchen Shi, Shuwei Ren, Jingdan Zhang, Yu Tian, Xiangling Yang, Huanliang Liu · 2023 · Biomolecules and Biomedicine
  12. Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies
    Ester Blanco, Noelia Silva-Pilipich, Ana Bocanegra, Luisa Chocarro, Antonio Procopio, Karina Ausín, Joaquín Fernández‐Irigoyen, Leticia Fernández, Nerea Razquin, Ana Igea et al. · 2024 · British Journal of Cancer
  13. miR-524-5p reduces the progression of the BRAF inhibitor-resistant melanoma
    Mai-Huong Nguyen, Chen-Huan Lin, Szumam Liu, Azusa Miyashita, Hironobu Ihn, Hsuan Lin, Chi‐Hou Ng, Jen-Chieh Tsai, Ming‐Hong Chen, Mu-Shiun Tsai et al. · 2020 · Neoplasia
  14. Liver X receptors and skeleton: Current state-of-knowledge
    Divya Goel, Divya Vohora · 2020 · Bone
  15. Liver X receptors and the hallmarks of aging: From molecular mechanisms to therapeutic opportunities
    Marc Poirot, Julio Buñay, Silia Ayadi, Sandrine Silvente‐Poirot, Philippe de Médina · 2025 · Ageing Research Reviews
  16. Molecular mechanism of liver X receptors in cancer therapeutics
    Qiang Wang, Jing Wang, Jiayou Wang, Heng Zhang · 2021 · Life Sciences
  17. Discovery of Spiro[pyrrolidine-3,3′-oxindole] LXRβ Agonists for the Treatment of Osteoporosis
    Hao Chen, Pei Hua, Dane Huang, Yuting Zhang, Huihao Zhou, Jun Xu, Qiong Gu · 2022 · Journal of Medicinal Chemistry
  18. Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer
    Mary Mazzotta Heckler, Tizita Zewde Zeleke, Shailaja D. Divekar, Aileen I. Fernandez, Deanna Marie Tiek, Jordan Woodrick, Alexander Farzanegan, Rabindra Roy, Aykut Üren, Susette C. Mueller et al. · 2016 · Oncotarget
  19. Prognostic role of liver X receptor‐alpha in resected stage II and III non‐small‐cell lung cancer
    Giulio Melloni, Piergiorgio Muriana, Alessandro Bandiera, Raffaella Fontana, Daniela Maggioni, Vincenzo E. A. Russo, Claudio Doglioni, Piero Zannini · 2016 · The Clinical Respiratory Journal
  20. Pathogenic Role of 25-Hydroxycholesterol in Cancer Development and Progression
    Sura Salman Ejam, Raed Obaid Saleh, Maria Jade Catalan Opulencia, Mazin A. A. Najm, Aziza Makhmudova, Abduladheem Turki Jalil, Walid Kamal Abdelbasset, Moaed Emran Al-Gazally, Ali Thaeer Hammid, Yasser Fakri Mustafa et al. · 2022 · Future Oncology
  21. RXR signaling targeted cancer therapy
    Wenrui Zhao, Suyao Li, Ruoxue Chen, Junjie Ni, Xuan Huang, Song Li, Xiaoling Lü, Xin Cao · 2023 · The Innovation Life
  22. New Insights in Prostate Cancer Development and Tumor Therapy: Modulation of Nuclear Receptors and the Specific Role of Liver X Receptors
    Laura Bousset, Amandine Rambur, Allan Fouache, Julio Buñay, Laurent Morel, Jean‐Marc A. Lobaccaro, Silvère Baron, Amalia Trousson, Cyrille de Joussineau · 2018 · International Journal of Molecular Sciences
  23. The critical function of metabolic reprogramming in cancer metastasis
    Sun‐Zhe Xie, Jun‐Jie Pan, Jianfeng Xu, Wenwei Zhu, Lun–Xiu Qin · 2022 · Aging and Cancer
  24. The environmental obesogen bisphenol A increases macrophage self-renewal
    Grace Ampem, Alexandra Junginger, Haidong Yu, Lajos Balogh, Julianna Thuróczy, Marion E. Schneider, Tamás Rőszer · 2019 · Cell and Tissue Research
  25. Type I-polarized BRAF-pulsed dendritic cells induce antigen-specific CD8+ T cells that impact BRAF-mutant murine melanoma
    Jessica Cintolo-Gonzalez, Jashodeep Datta, Shuwen Xu, Meera Gupta, Rajasekharan Somasundaram, Brian J. Czerniecki · 2015 · Melanoma Research
  26. Activation of Liver X Receptor α Sensitizes Mice to T‐Cell Mediated Hepatitis
    Li Gao, Bin Li, Jingyuan Wang, Danhua Shen, Min Yang, Runzi Sun, Hung‐Chun Tung, Meishu Xu, Songrong Ren, Min Zhang et al. · 2020 · Hepatology Communications
  27. LXR Inhibits Proliferation of Human Breast Cancer Cells through the PI3K-Akt Pathway
    Treska S. Hassan, Aida Paniccia, Vincenzo E. A. Russo, Knut Rune Steffensen · 2015 · Nuclear Receptor Research
  28. Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core
    Colin M. Tice, Paul Bart Noto, Kristi Yi Fan, Wei Liang Zhao, Stephen D. Lotesta, Chengguo Dong, Andrew P. Marcus, Ya‐Jun Zheng, Guozhou Chen, Zhongren Wu et al. · 2016 · Bioorganic & Medicinal Chemistry Letters
  29. Nuclear receptors behind the therapeutic effects of plant sterols on metabolism: A review
    María C. Brañes, Raimundo Gillet, Rodrigo B. Valenzuela · 2024 · Lipids
  30. Role of the liver X receptors in skin physiology: Putative pharmacological targets in human diseases
    Zangbéwendé Guy Ouedraogo, Allan Fouache, Amalia Trousson, Silvère Baron, Jean‐Marc A. Lobaccaro · 2017 · Chemistry and Physics of Lipids
  31. Are Synthetic Compounds that Silence the Liver-X-Receptor the Next Generation of Anti-cancer Drugs?
    Knut Rune Steffensen · 2015 · Cancer Cell
  32. Reduction of fibrosis and immune suppressive cells in ErbB2-dependent tumorigenesis by an LXR agonist
    Sheng Gao, Hongyan Yuan, Lü Jin, Suman Ranjit, Julia Panov, Xun Lu, Moshe Levi, Robert I. Glazer · 2021 · PLoS ONE
  33. 1α-Hydroxy derivatives of 7-dehydrocholesterol are selective liver X receptor modulators
    Kaori Endo‐Umeda, Atsushi Aoyama, Masato Shimizu, Minoru Ishikawa, Yuichi Hashimoto, Sachiko Yamada, Makoto Makishima · 2017 · The Journal of Steroid Biochemistry and Molecular Biology
  34. RETRACTED ARTICLE: Liver X receptors constrain tumor development and metastasis dissemination in PTEN-deficient prostate cancer
    Anthony Alioui, Julie Dufour, Valerio Leoni, Anke Loregger, Martina Moeton, Luigi Iuliano, Chiara Zerbinati, Amandine Septier, Pierre Val, Allan Fouache et al. · 2017 · Nature Communications · Retracted
  35. Oxalomalate suppresses metastatic melanoma through IDH-targeted stress response to ROS
    Sung Hwan Kim, Hyun Jin Kim, Jin Hyup Lee, Jeen‐Woo Park · 2019 · Free Radical Research
  36. Lipoprotein Deprivation Reveals a Cholesterol-Dependent Therapeutic Vulnerability in Diffuse Glioma Metabolism
    James Wood, Salah Abdelrazig, Sergey Evseev, Catherine A. Ortori, Marcos Castellanos‐Uribe, Sean Tobias May, David A. Barrett, Mohammed Diksin, Sajib Chakraborty, Dong‐Hyun Kim et al. · 2022 · Cancers
  37. A Novel Liver X Receptor Inverse Agonist Impairs Cholesterol and Phospholipid Metabolism and Induces Apoptosis and Necroptosis in Pancreatic Ductal Adenocarcinoma Cells
    Scott Widmann, Shivangi Srivastava, Chin‐Yo Lin · 2023 · Receptors
  38. ATF4/TXNIP/REDD1/mTOR signaling mediates the antitumor activities of liver X receptor in pancreatic cancers
    Zhikang Chen, Xiaobo Lai, Hui Ding, Aijun Zhang, Yufei Sun, Jianhua Ling, Paul J. Chiao, Zihua Chen, Xuefeng Xia · 2022 · Cancer Innovation
  39. Liver X receptors induce antiproliferative effects in basal‐like breast cancer
    Mads Haugland Haugen, Hedda von der Lippe Gythfeldt, Eivind Valen Egeland, Lisa Svartdal Normann, Abhilash D. Pandya, Lise‐Lotte Vedin, Siri Juell, Ellen M. Tenstad, Geir Frode Øy, Alexandr Kristian et al. · 2023 · Molecular Oncology
  40. A Subset of Nuclear Receptors are Uniquely Expressed in Uveal Melanoma Cells
    Kenneth E. Huffman, Ryan M. Carstens, Elisabeth D. Martínez · 2015 · Frontiers in Endocrinology
  41. In vivo assessment of the vascular disrupting effect of M410 by DCE-MRI biomarker in a rabbit model of liver tumor
    RUI-MENG YANG, Yong Zou, Danping Huang, Shengsheng Lai, Xiangdong Xu, Xinhua Wei, HAN-ZHENG CHANG, Tongkun Huang, LI WANG, Wenjie Tang et al. · 2014 · Oncology Reports
  42. Pivotal role of intestinal cholesterol and nuclear receptor LXR in metabolic liver steatohepatitis and hepatocarcinoma
    Elena Piccinin, Maria Arconzo, Emanuela Pasculli, Angela Fulvia Tricase, Silvia Cultrera, Justine Bertrand‐Michel, Nicolas Loiseau, Gaetano Villani, Hervé Guillou, Antonio Moschetta · 2024 · Cell & Bioscience
  43. Lipids and prostate cancer adenocarcinoma
    Anthony Alioui, O. Celhay, Silvère Baron, Jean‐Marc A. Lobaccaro · 2014 · Clinical Lipidology
  44. A new weapon against metastatic melanoma
    Katie Kingwell · 2014 · Nature Reviews Drug Discovery
  45. Targeting Liver X Receptors in Cancer Drug Discovery
    Asitha Premaratne, Abhinav Bagchi, Shinjini Basu, Jan-Ακε Gustafsson, Chin‐Yo Lin · 2024 · Receptors
  46. Transcriptional and non-transcriptional roles of LXRs in cancer cells
    2015 · Receptors & Clinical Investigation
  47. A transcriptional mechanism involving R-loop, m6A modification and RNA abasic sites regulates an enhancer RNA of APOE
    Jason A. Watts, Christopher Grunseich, Yesenia Rodriguez, Yaojuan Liu, Dongjun Li, Joshua T. Burdick, Alan Bruzel, Robert J. Crouch, Robert W. Mahley, Samuel H. Wilson et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  48. Regulation of neurogenesis and neuronal migration by Rrm2 and Timp3 following seizures
    Adebayo Olukayode Adeyeye, Parul Varma, Nico Enerlan, Marissa Olga Coppin, Jenny Hsieh · 2025 · Neurobiology of Disease
  49. A Stable Luciferase Reporter System to Characterize LXR Regulation by Oxysterols and Novel Ligands
    Samantha A. Hutchinson, James L. Thorne · 2019 · Methods in molecular biology
  50. Receptor agonist/antagonist-incorporated anticancer nanodrugs: Design, materials, and strategies
    Shi-Jie Hao, Shun‐Yu Wu, Yun-Kai Chang, Fu‐Gen Wu · 2024 · Materials Today
  51. Preclinical Models of Brain Metastasis
    Lucía Zhu, Manuel Valiente · 2020 · Springer eBooks
  52. Lipid metabolism and signaling in cancer
    Elena Piccinin, James Mukasa Ntambi, Antonio Moschetta · 2020 · Elsevier eBooks
  53. Immunosuppressive triangle depletion through the combination punches strategy for enhanced immunotherapy
    Qianhua Feng, Huifang Xiao, Cuixia Zheng, Xueli Zhang, Zeying Wang, Lei Wang · 2021 · Applied Materials Today
  54. Retraction Note: Liver X receptors constrain tumor development and metastasis dissemination in PTEN-deficient prostate cancer
    Anthony Alioui, Julie Dufour, Valerio Leoni, Anke Loregger, Martina Moeton, Luigi Iuliano, Chiara Zerbinati, Amandine Septier, Pierre Val, Allan Fouache et al. · 2018 · Nature Communications · Retracted
  55. Nucleolar protein 7 facilitates melanoma progression and metastasis via HIF-1ɑ/PI3K/AKT/ERK axis
    Yumei Li, Fan Chen, Weiyu Shen, Bifei Li, Ning Zheng, Yusheng Lu, Vladimir L. Katanaev, Lee Jia · 2020 · Research Square
  56. Liver X receptors—a new target for cancer treatment
    Liu Xiaowang, Kaiqiang Lu, Ting Xiong, Zhou Zhigang · 2016
  57. 強心配糖体ウアバインのアグリコン「ウアバゲニン」の新規生理活性
    Satoru Tamura, Maiko Okada, Minoru Ueda · 2018 · KAGAKU TO SEIBUTSU
  58. Activation of Lxrβ Causes Metabolic Reprogramming and Sensitizes Solid Tumors to Bcl-xL Inhibition Mediated Apoptosis
    Chiaki Tsuge Ishida, Yiru Zhang, Elena Bianchetti, Chang Shu, Maria J. Sanchez‐Quintero, Catarina Maria Quinzii, Mike‐Andrew Westhoff, Georg Karpel‐Massler, Peter Canoll, Markus David Siegelin · 2018 · SSRN Electronic Journal
  59. [The direct isotopic cystography in the study of the vesico-ureteral reflux (author's transl)].
    J C Fombellida Cortázar, J Simón González, M.C. Cano Terol, J Alonso Monfort, I. Zamora Marti · 1978 · PubMed
  60. Faculty Opinions recommendation of Lxr/apoe activation restricts innate immune suppression in cancer.
    Philippe Saas, Sylvain Perruche · 2018 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  61. Data from Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti–PD-1 Therapy Efficacy
    Anne Montfort, Florie A. Bertrand, Julia Rochotte, Julia Gilhodes, Thomas Filleron, Jean Milhès, Carine Dufau, Caroline Imbert, Joëlle Riond, Marie Tosolini et al. · 2023
  62. Data from Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti–PD-1 Therapy Efficacy
    Anne Montfort, Florie A. Bertrand, Julia Rochotte, Julia Gilhodes, Thomas Filleron, Jean Milhès, Carine Dufau, Caroline Imbert, Joëlle Riond, Marie Tosolini et al. · 2023
  63. Integrated Whole Exome and Transcriptome Sequencing in Cholesterol Metabolism in Melanoma: Systematic Review
    Mohamed Mahmoud Nour Eldein, Wesam Ahmed Nasif, Wesam Ahmed Nasif, Amr Ahmed Amin, Gad Allah Modawe, Abdullatif Taha Babakr · 2024 · Sudan Journal of Medical Sciences
  64. Unlocking the potential of Liver X Receptors: A new era in metabolic regulation
    Imroze Singh, Suman Kalia · 2025 · International Journal of Pharmacology and Clinical Research
  65. Comprehensive analysis reveals MCM4 as a biomarker for guiding therapies and immunomodulatory role in skin cutaneous melanoma
    Wei Ou, Jiang Zhou, Zhenhua Huang, XinLiang Yang, Xiaohong Liu, Wenjian Zuo, ZhiYong Luo, Min Su · 2025 · Journal of Cancer
  66. Additional file 1 of Pivotal role of intestinal cholesterol and nuclear receptor LXR in metabolic liver steatohepatitis and hepatocarcinoma
    Elena Piccinin, Maria Arconzo, Emanuela Pasculli, Angela Fulvia Tricase, Silvia Cultrera, Justine Bertrand‐Michel, Nicolas Loiseau, Gaetano Villani, Hervé Guillou, Antonio Moschetta · 2024 · Figshare
  67. Additional file 2 of Pivotal role of intestinal cholesterol and nuclear receptor LXR in metabolic liver steatohepatitis and hepatocarcinoma
    Elena Piccinin, Maria Arconzo, Emanuela Pasculli, Angela Fulvia Tricase, Silvia Cultrera, Justine Bertrand‐Michel, Nicolas Loiseau, Gaetano Villani, Guillou, Hervé, Antonio Moschetta · 2024 · Figshare
  68. Epigenetic regulation of gene expression during melanocyte and melanoma development
    Patrick Laurette · 2016 · theses.fr (ABES)
  69. Nouveaux modèles pour le criblage de modulateurs / perturbateurs des voies de signalisation régulées par les Liver X receptors
    Allan Fouache · 2018 · theses.fr (ABES)
  70. Rôle de la sphingosine kinase-1 dans la réponse immunitaire anti-tumorale et dans le traitement du mélanome par immunothérapie
    Caroline Imbert · 2018 · theses.fr (ABES)
  71. Cancer de la prostate et mécanismes de résistance à la castration : étude du rôle des récepteurs nucléaires LXR
    Laura Bousset · 2019 · theses.fr (ABES)
  72. MARCH2 prevents doxorubicin-induced cardiomyopathy by stabilizing NR1H2 and promoting clearance of apoptotic cardiomyocytes
    liu shuolin, Yiran E. Li, Tingfang Zhu, Laihai Zhang, Cong Yang, Yaguang Bi, Chenglong Bao, Ronggui Hu, Junbo Ge, Yingmei Zhang · 2026 · Nature Communications
  73. Integrating proteomics and metabolomics to reveal MAT2A for metabolic reprogramming in non-small cell lung cancer cells
    Yimin Chen, Yuxi Liu, Zhenyun Zhu, Anqi Ding, Yuying Suo, Cheng Wang, Xiongjun Wang, Hu Zhou, Qiyu Fang, Qian Liu · 2026 · iScience
  74. Three decades of liver X receptor agonist chemistry: Structural motifs, structure-activity relationship, and therapeutic prospects
    Norberta Delporte, Aurélie Lagarde, Pierre Chalard, Silvère Baron, Amalia Trousson, Jean‐Marc A. Lobaccaro, Isabelle Thomas · 2026 · The Journal of Steroid Biochemistry and Molecular Biology
  75. BindingDB Entry 50011862: Discovery of new LXRβ agonists as glioblastoma inhibitors.
    BindingDB · 2022 · UC San Diego
  76. BindingDB Entry 50008390: Development of novel liver X receptor modulators based on a 1,2,4-triazole scaffold.
    BindingDB · 2021 · UC San Diego
  77. BindingDB Entry 50047831: Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core.
    BindingDB · 2018 · UC San Diego
  78. BindingDB Entry 50003012: Recent Advances in the Medicinal Chemistry of Liver X Receptors.
    BindingDB · 2020 · UC San Diego
  79. BindingDB Entry 50019169: Discovery of Spiro[pyrrolidine-3,3'-oxindole] LXRβ Agonists for the Treatment of Osteoporosis.
    BindingDB · 2024 · UC San Diego